Combinatory effects of gemcitabine and inhibitors targeting PI3K-Akt-mTOR pathway in human pancreatic and breast cancer cells.
Datasets usually provide raw data for analysis. This raw data often comes in spreadsheet form, but can be any collection of data, on which analysis can be performed.
The values represent the average of three independent experiments.b
IC50 values between combination treatment vs. Gem along were analyzed statistically by performing t tests.
Abbreviations: Gem, gemcitabine; TCN, tricirbine; Rap, rapamycin.